Skip to content

A comparative study for the effects of escitalopram and duloxetine on anhedonia in depression

A comparative study for the effects of escitalopram and duloxetine on anhedonia in depression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900023492
Enrollment
Unknown
Registered
2019-05-31
Start date
2019-05-30
Completion date
Unknown
Last updated
2019-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Major depressive disorder

Interventions

Group 1:Escitalopram
Group 2:Duloxetine

Sponsors

ZhongDa Hospital, School of Medicine, Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged between 18–65 years; 2. Depressive episode of at least moderate severity according to ICD-10; 3. Written informed consent of participation.

Exclusion criteria

Exclusion criteria: 1. Comorbidity with psychotic symptoms, schizophrenia, schizotypal or delusional disorders, bipolar disorder, mental retardation, active addiction to alcohol or other psychoactive substances excluding nicotine and caffeine, organic-including symptomatic-mental disorders; 2. Severe physical or neurological diseases; 3. Patients with severe suicidal tendencies; 4. pregnancy for women; 5. A history of treatment-resistant depression; 6. Patients who had previously received treatment with either escitalopram or duloxetine; 7. Concomitant use of any psychoactive drug (or any drug with a psychotropic component), except zolpidem or zaleplon as needed for sleep.

Design outcomes

Primary

MeasureTime frame
Snaith-Hamilton Pleasure Scale;17-item Hamilton Depression Rating Scale;

Countries

China

Contacts

Public ContactYongggui Yuan

ZhongDa Hospital, School of Medicine, Southeast University

yygylh2000@sina.com+86 13913939082

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026